Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/23/2026 | Q4 | $2.3B | -- | -- | $3.20 | -- |
| 11/10/2025 | Q3 | $1.8B | $2.1B | $2.72 | $2.94 | -$0.22 |
| 08/04/2025 | Q2 | $1.5B | $1.9B | $2.61 | $2.64 | -$0.03 |
| 05/12/2025 | Q1 | $1.4B | $1.6B | $2.59 | $2.71 | -$0.12 |
| 02/24/2025 | Q4 | $1.4B | $1.5B | $3.25 | $3.42 | -$0.17 |
| 10/21/2024 | Q3 | $1.3B | $1.4B | $2.95 | $2.87 | $0.08 |
| 07/22/2024 | Q2 | $1.2B | $1.3B | $2.78 | $2.82 | -$0.04 |
| 04/22/2024 | Q1 | $1.2B | $1.2B | $2.56 | $2.61 | -$0.05 |
| 02/26/2024 | Q4 | $1.2B | $1.2B | $2.71 | -- | -- |
| 09/30/2023 | Q3 | -- | $1.1B | $2.65 | -- | -- |
| 06/30/2023 | Q2 | -- | $978.8M | $2.24 | -- | -- |
| 03/31/2023 | Q1 | -- | $868.2M | $1.98 | -- | -- |
| 12/31/2022 | Q4 | -- | $865.8M | $2.06 | -- | -- |
| 09/30/2022 | Q3 | -- | $731.9M | $1.80 | -- | -- |
| 06/30/2022 | Q2 | -- | $667.7M | $1.53 | -- | -- |
| 03/31/2022 | Q1 | -- | $573.7M | $1.14 | -- | -- |
| 12/31/2021 | Q4 | -- | $670M | $1.63 | -- | -- |
| 09/30/2021 | Q3 | -- | $588.1M | $1.49 | -- | -- |
| 06/30/2021 | Q2 | -- | $499.8M | $1.18 | -- | -- |
| 03/31/2021 | Q1 | -- | $437.6M | $0.93 | -- | -- |
| 12/31/2020 | Q4 | -- | $423.6M | $0.93 | -- | -- |
| 09/30/2020 | Q3 | -- | $386M | $0.85 | -- | -- |
| 06/30/2020 | Q2 | -- | $332.8M | $0.65 | -- | -- |
| 03/31/2020 | Q1 | -- | $407.4M | $0.83 | -- | -- |
| 12/31/2019 | Q4 | -- | $389.5M | $0.84 | -- | -- |
| 09/30/2019 | Q3 | -- | $353.1M | $0.79 | -- | -- |
| 06/30/2019 | Q2 | -- | $321.8M | $0.62 | -- | -- |
| 03/31/2019 | Q1 | -- | $276.1M | $0.45 | -- | -- |
| 12/31/2018 | Q4 | -- | $281.8M | $0.39 | -- | -- |
| 09/30/2018 | Q3 | -- | $286M | $0.61 | -- | -- |
| 06/30/2018 | Q2 | -- | $272.1M | $0.48 | -- | -- |
| 03/31/2018 | Q1 | -- | $246.9M | $0.53 | -- | -- |
| 12/31/2017 | Q4 | -- | -- | -- | -- | -- |
| 09/30/2017 | Q3 | -- | -- | -- | -- | -- |
| 06/30/2017 | Q2 | -- | -- | -- | -- | -- |
| 03/31/2017 | Q1 | -- | -- | -- | -- | -- |
| 12/31/2016 | Q4 | -- | -- | -- | -- | -- |
| 09/30/2016 | Q3 | -- | -- | -- | -- | -- |
| 06/30/2016 | Q2 | -- | -- | -- | -- | -- |
| 03/31/2016 | Q1 | -- | -- | -- | -- | -- |
Kaspi.kz JSC reported $2.1B worth of top line sales in its most recent quarter.
Kaspi.kz JSC announced earnings per share of $2.72 which represents a miss of analyst forecast a $2.94 per share.
Kaspi.kz JSC reported -- that represents -- per share over the last quarter.
Kaspi.kz JSC's earnings are forecast to decrease from $11.57 per share to $11.12 per share next year representing a decrease of -3.41%.
Kaspi.kz JSC's next earnings date is February 23, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.